FGF-23 in bone biology

Pediatric Nephrology

Volumn 25, Issue 4, 2010, Pages 603-608

  Wesseling Perry, Katherine ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Chronic kidney disease; Dentin matrix protein 1; Fibroblast growth factor 23; Matrix extracellular phosphoglycoprotein; Phosphate regulating endopeptidase homolog; Skeletal mineralization

Indexed keywords

CARBONATE DEHYDRATASE III; CARBONATE DEHYDRATASE XII; CARRIER PROTEIN; DENTIN MATRIX PROTEIN 1; FIBROBLAST GROWTH FACTOR 23; KLOTHO PROTEIN; MATRIX EXTRACELLULAR PHOSPHOGLYCOPROTEIN; PHOSPHATE REGULATING NEUTRAL ENDOPEPTIDASE; SODIUM DEPENDENT CITRATE TRANSPORTER; THROMBOSPONDIN; UNCLASSIFIED DRUG;

BONE METABOLISM; BONE MINERALIZATION; CHRONIC KIDNEY DISEASE; CONFERENCE PAPER; DISEASE COURSE; HUMAN; HYPERPARATHYROIDISM; NONHUMAN; OSTEOCYTE; OSTEOMALACIA; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN PHOSPHORYLATION; PROTEIN PROTEIN INTERACTION; REGULATORY MECHANISM; RENAL OSTEODYSTROPHY;

ANIMALS; BONE AND BONES; DISEASE MODELS, ANIMAL; EXTRACELLULAR MATRIX PROTEINS; FIBROBLAST GROWTH FACTORS; GLYCOPROTEINS; HUMANS; KIDNEY FAILURE, CHRONIC; OSTEOCYTES; OSTEOMALACIA; PHOSPHOPROTEINS;

EID: 77951253593     PISSN: 0931041X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00467-009-1384-6     Document Type: Conference Paper

References (53)

1. A Levin GL Bakris M Molitch M Smulders J Tian LA Williams DL Andress 2007 Prevalence of abnormal serum vitamin D, PTH, calcium, and phosphorus in patients with chronic kidney disease: results of the study to evaluate early kidney disease Kidney Int 71 31 38 10.1038/sj.ki.5002009 1:CAS:528: DC%2BD28XhtlSqtbnK 17091124 (Pubitemid 44967731)
2. National Kidney Foundation 2003 K/DOQI clinical practice guidelines for bone metabolism and disease in chronic kidney disease Am J Kidney Dis 42 S1 S201
3. National Kidney Foundation 2005 K/DOQI clinical practice guidelines for bone metabolism and disease in children with chronic kidney disease Am J Kidney Dis 46 S1 S121
4. O Gutierrez T Isakova E Rhee A Shah J Holmes G Collerone H Jüppner M Wolf 2005 Fibroblast growth factor-23 mitigates hyperphosphatemia but accentuates calcitriol deficiency in chronic kidney disease J Am Soc Nephrol 16 2205 2215 10.1681/ASN.2005010052 1:CAS:528:DC%2BD2MXms1egsLs%3D 15917335 (Pubitemid 41716454)
5. Y Yoshiko H Wang T Minamizaki C Ijuin R Yamamoto S Suemune K Kozai K Tanne JE Aubin N Maeda 2007 Mineralized tissue cells are a principal source of FGF23 Bone 40 6 1565 1573 10.1016/j.bone.2007.01.017 1:CAS:528: DC%2BD2sXlsF2nu78%3D 17350357 (Pubitemid 46756409)
6. T Shimada M Kakitani Y Yamazaki H Hasegawa Y Takeuchi T Fujita S Fukumoto K Tomizuka T Yamashita 2004 Targeted ablation of Fgf23 demonstrates an essential physiological role of FGF23 in phosphate and vitamin D metabolism J Clin Invest 113 561 568 1:CAS:528:DC%2BD2cXhsFKhsbs%3D 14966565 (Pubitemid 38542505)
7. D Sitara MS Razzaque M Hesse S Yoganathan T Taguchi RG Erben H Jüppner B Lanske 2004 Homozygous ablation of fibroblast growth factor-23 results in hyperphosphatemia and impaired skeletogenesis, and reverses hypophosphatemia in Phex-deficient mice Matrix Biol 23 421 432 10.1016/j.matbio.2004.09.007 1:CAS:528:DC%2BD2cXhtVaqsLnI 15579309 (Pubitemid 39576657)
8. ADHR consortium 2000 Autosomal dominant hypophosphataemic rickets is associated with mutations in FGF23 Nat Genet 26 345 348 10.1038/81664
9. H Wang Y Yoshiko R Yamamoto T Minamizaki K Kozai K Tanne JE Aubin N Maeda 2008 Overexpression of fibroblast growth factor 23 suppresses osteoblast differentiation and matrix mineralization in vitro J Bone Miner Res 23 939 948 10.1359/jbmr.080220 1:CAS:528:DC%2BD1cXnvVGjsL4%3D 18282132 (Pubitemid 351768812)
10. K Wesseling-Perry RC Pereira H Wang RM Elashoff S Sahney B Gales H Jüppner IB Salusky 2009 Relationship between plasma FGF-23 concentration and bone mineralization in children with renal failure on peritoneal dialysis J Clin Endocrinol Metab 94 2 511 517 10.1210/jc.2008-0326 1:CAS:528: DC%2BD1MXhvFCqsbo%3D 19050056
11. R Guo PS Rowe S Liu LG Simpson ZS Xiao LD Quarles 2002 Inhibition of MEPE cleavage by Phex Biochem Biophys Res Commun 297 38 45 10.1016/S0006-291X(02) 02125-3 1:CAS:528:DC%2BD38Xms1GntrY%3D 12220505
12. A Martin V David JS Laurence PM Schwarz EM Lafer AM Hedge PS Rowe 2008 Degradation of MEPE, DMP1, and release of SIBLING ASARM-peptides (minhibins): ASARM-peptide(s) are directly responsible for defective mineralization in HYP Endocrinology 149 1757 1772 10.1210/en.2007-1205 1:CAS:528:DC%2BD1cXktVeqs7o%3D 18162525 (Pubitemid 351468353)
13. T Shimada S Mizutani T Muto T Yoneya R Hino S Takeda Y Takeuchi T Fujita S Fukumoto T Yamashita 2001 Cloning and characterization of FGF23 as a causative factor of tumor-induced osteomalacia Proc Natl Acad Sci USA 98 6500 6505 10.1073/pnas.101545198 1:CAS:528:DC%2BD3MXktVWktLs%3D 11344269 (Pubitemid 32488266)
14. KB Jonsson R Zahradnik T Larsson KE White T Sugimoto Y Imanishi T Yamamoto G Hampson H Koshiyama O Ljunggren K Oba IM Yang A Miyauchi MJ Econs J Lavigne H Jüppner 2003 Fibroblast growth factor 23 in oncogenic osteomalacia and X-linked hypophosphatemia N Engl J Med 348 1656 1663 10.1056/NEJMoa020881 1:CAS:528:DC%2BD3sXjtFSnsbk%3D 12711740 (Pubitemid 36459471)
15. Y Yamazaki R Okazaki M Shibata Y Hasegawa K Satoh T Tajima Y Takeuchi T Fujita K Nakahara T Yamashita S Fukumoto 2002 Increased circulatory level of biologically active full-length FGF-23 in patients with hypophosphatemic rickets/osteomalacia J Clin Endocrinol Metab 87 4957 4960 10.1210/jc.2002-021105 1:CAS:528:DC%2BD38Xos1ynsLk%3D 12414858 (Pubitemid 35316332)
16. KE White KB Jonsson G Carn G Hampson TD Spector M Mannstadt B Lorenz-Depiereux A Miyauchi IM Yang O Ljunggren T Meitinger TM Strom H Jüppner MJ Econs 2001 The autosomal dominant hypophosphatemic rickets (ADHR) gene is a secreted polypeptide overexpressed by tumors that cause phosphate wasting J Clin Endocrinol Metab 86 497 500 10.1210/jc.86.2.497 1:CAS:528:DC%2BD3MXht1Kns70%3D 11157998 (Pubitemid 32207449)
17. SM De Beur RB Finnegan J Vassiliadis B Cook D Barberio S Estes P Manavalan J Petroziello SL Madden JY Cho R Kumar MA Levine SC Schiavi 2002 Tumors associated with oncogenic osteomalacia express genes important in bone and mineral metabolism J Bone Miner Res 17 1102 1110 10.1359/jbmr.2002.17.6.1102 12054166 (Pubitemid 34535149)
18. T Shimada H Hasegawa Y Yamazaki T Muto R Hino Y Takeuchi T Fujita K Nakahara S Fukumoto T Yamashita 2004 FGF-23 is a potent regulator of vitamin D metabolism and phosphate homeostasis J Bone Miner Res 19 429 435 10.1359/JBMR.0301264 1:CAS:528:DC%2BD2cXisFCrsbg%3D 15040831 (Pubitemid 38787398)
19. K Kato C Jeanneau MA Tarp A et-Pages B Lorenz-Depiereux EP Bennett U Mandel TM Strom H Clausen 2006 Polypeptide GalNAc-transferase T3 and familial tumoral calcinosis. Secretion of fibroblast growth factor 23 requires O-glycosylation J Biol Chem 281 18370 18377 10.1074/jbc.M602469200 1:CAS:528:DC%2BD28XmsVagsbg%3D 16638743 (Pubitemid 44035494)
20. K Araya S Fukumoto R Backenroth Y Takeuchi K Nakayama N Ito N Yoshii Y Yamazaki T Yamashita J Silver T Igarashi T Fujita 2005 A novel mutation in fibroblast growth factor 23 gene as a cause of tumoral calcinosis J Clin Endocrinol Metab 90 5523 5527 10.1210/jc.2005-0301 1:CAS:528: DC%2BD2MXhtFWjt7%2FF 16030159 (Pubitemid 41415453)
21. A Benet-Pages P Orlik TM Strom B Lorenz-Depiereux 2005 An FGF23 missense mutation causes familial tumoral calcinosis with hyperphosphatemia Hum Mol Genet 14 385 390 10.1093/hmg/ddi034 1:CAS:528:DC%2BD2MXkt1Wktw%3D%3D 15590700 (Pubitemid 40220655)
22. T Larsson X Yu SI Davis MS Draman SD Mooney MJ Cullen KE White 2005 A novel recessive mutation in fibroblast growth factor-23 causes familial tumoral calcinosis J Clin Endocrinol Metab 90 2424 2427 10.1210/jc.2004-2238 1:CAS:528:DC%2BD2MXjsFWis7g%3D 15687325 (Pubitemid 40586293)
23. X Bai Q Dinghong D Miao D Goltzman AC Karaplis 2009 Klotho ablation converts the biochemical and skeletal alterations in FGF23 (R176Q) transgenic mice to a Klotho-deficient phenotype Am J Physiol Endocrinol Metab 296 E79 E88 10.1152/ajpendo.90539.2008 1:CAS:528:DC%2BD1MXpsFCgtg%3D%3D 18984852
24. T Krajisnik P Bjorklund R Marsell O Ljunggren G Akerstrom KB Jonsson G Westin TE Larsson 2007 Fibroblast growth factor-23 regulates parathyroid hormone and 1alpha-hydroxylase expression in cultured bovine parathyroid cells J Endocrinol 195 125 131 10.1677/JOE-07-0267 1:CAS:528:DC%2BD2sXhtlWiu77P 17911404 (Pubitemid 350056006)
25. IZ Ben-Dov H Galitzer V Lavi-Moshayoff R Goetz O Kuro M Mohammadi R Sirkis T Naveh-Many J Silver 2007 The parathyroid is a target organ for FGF23 in rats J Clin Invest 117 4003 4008 1:CAS:528:DC%2BD2sXhsValsLzL 17992255 (Pubitemid 350224109)
26. X Yu Y Sabbagh SI Davis MB Demay KE White 2005 Genetic dissection of phosphate- and vitamin D-mediated regulation of circulating Fgf23 concentrations Bone 36 971 977 10.1016/j.bone.2005.03.002 1:CAS:528:DC%2BD2MXltFSltL4%3D 15869926 (Pubitemid 40797997)
27. TK Barthel DR Mathern GK Whitfield CA Haussler HA Hopper JC Hsieh SA Slater G Hsieh M Kaczmarska PW Jurutka OI Kolek FK Ghishan MR Haussler 2007 1, 25-Dihydroxyvitamin D3/VDR-mediated induction of FGF23 as well as transcriptional control of other bone anabolic and catabolic genes that orchestrate the regulation of phosphate and calcium mineral metabolism J Steroid Biochem Mol Biol 103 381 388 10.1016/j.jsbmb.2006.12.054 1:CAS:528: DC%2BD2sXjt1Wgurc%3D 17293108 (Pubitemid 46415670)
28. DM Antoniucci T Yamashita AA Portale 2006 Dietary phosphorus regulates serum fibroblast growth factor-23 concentrations in healthy men J Clin Endocrinol Metab 91 3144 3149 10.1210/jc.2006-0021 1:CAS:528: DC%2BD28XosFGht78%3D 16735491 (Pubitemid 44271770)
29. SA Burnett SC Gunawardene FR Bringhurst H Jüppner H Lee JS Finkelstein 2006 Regulation of C-terminal and intact FGF-23 by dietary phosphate in men and women J Bone Miner Res 21 1187 1196 10.1359/jbmr.060507 1:CAS:528:DC%2BD28XotlKrs7Y%3D 16869716 (Pubitemid 44128331)
30. T Kawata Y Imanishi K Kobayashi T Miki A Arnold M Inaba Y Nishizawa 2007 Parathyroid hormone regulates fibroblast growth factor-23 in a mouse model of primary hyperparathyroidism J Am Soc Nephrol 18 2683 2688 10.1681/ASN.2006070783 1:CAS:528:DC%2BD2sXht1Krs7jJ 17855636 (Pubitemid 47531195)
31. M Riminucci MT Collins NS Fedarko N Cherman A Corsi KE White S Waguespack A Gupta T Hannon MJ Econs P Bianco RP Gehron 2003 FGF-23 in fibrous dysplasia of bone and its relationship to renal phosphate wasting J Clin Invest 112 683 692 1:CAS:528:DC%2BD3sXntlSiurs%3D 12952917 (Pubitemid 38057709)
32. WW Brown H Jüppner CB Langman H Price EG Farrow KE White KL McCormick 2009 Hypophosphatemia with elevations in serum fibroblast growth factor 23 in a child with Jansen's metaphyseal chondrodysplasia J Clin Endocrinol Metab 94 17 20 10.1210/jc.2008-0220 1:CAS:528:DC%2BD1MXptVKmsw%3D%3D 18854401
33. JQ Feng LM Ward S Liu Y Lu Y Xie B Yuan X Yu F Rauch SI Davis S Zhang H Rios MK Drezner LD Quarles LF Bonewald KE White 2006 Loss of DMP1 causes rickets and osteomalacia and identifies a role for osteocytes in mineral metabolism Nat Genet 38 1310 1315 10.1038/ng1905 1:CAS:528:DC%2BD28XhtFeisbjE 17033621 (Pubitemid 44646294)
34. S Liu W Tang J Fang J Ren H Li Z Xiao LD Quarles 2009 Novel regulators of Fgf23 expression and mineralization in Hyp bone Mol Endocrinol 23 1505 1518 10.1210/me.2009-0085 1:CAS:528:DC%2BD1MXhtFCjsrnF 19556340
35. B Yuan M Takaiwa TL Clemens JQ Feng R Kumar PS Rowe Y Xie MK Drezner 2008 Aberrant Phex function in osteoblasts and osteocytes alone underlies murine X-linked hypophosphatemia J Clin Invest 118 722 734 1:CAS:528: DC%2BD1cXhsFOms7k%3D 18172553 (Pubitemid 351206560)
36. S Liu W Tang J Zhou L Vierthaler LD Quarles 2007 Distinct roles for intrinsic osteocyte abnormalities and systemic factors in regulation of FGF23 and bone mineralization in Hyp mice Am J Physiol Endocrinol Metab 293 E1636 E1644 10.1152/ajpendo.00396.2007 1:CAS:528:DC%2BD2sXhsVGls7vO 17848631 (Pubitemid 350255114)
37. PS Rowe N Matsumoto OD Jo RN Shih J Oconnor MP Roudier S Bain S Liu J Harrison N Yanagawa 2006 Correction of the mineralization defect in hyp mice treated with protease inhibitors CA074 and pepstatin Bone 39 773 786 10.1016/j.bone.2006.04.012 1:CAS:528:DC%2BD28XpsVOhtLs%3D 16762607 (Pubitemid 44335882)
38. WN Addison Y Nakano T Loisel P Crine MD McKee 2008 MEPE-ASARM peptides control extracellular matrix mineralization by binding to hydroxyapatite: an inhibition regulated by PHEX cleavage of ASARM J Bone Miner Res 23 1638 1649 10.1359/jbmr.080601 1:CAS:528:DC%2BD1cXht1OntLfP 18597632
39. S Liu TA Brown J Zhou ZS Xiao H Awad F Guilak LD Quarles 2005 Role of matrix extracellular phosphoglycoprotein in the pathogenesis of X-linked hypophosphatemia J Am Soc Nephrol 16 1645 1653 10.1681/ASN.2004121060 1:CAS:528:DC%2BD2MXls1eiu74%3D 15843468 (Pubitemid 41721870)
40. I Maciejewska C Cowan K Svoboda WT Butler R D'Souza C Qin 2009 The NH2-terminal and COOH-terminal fragments of dentin matrix protein 1 (DMP1) localize differently in the compartments of dentin and growth plate of bone J Histochem Cytochem 57 155 166 10.1369/jhc.2008.952630 1:CAS:528: DC%2BD1MXit1KhsLo%3D 18854597
41. PH Tartaix M Doulaverakis A George LW Fisher WT Butler C Qin E Salih M Tan Y Fujimoto L Spevak AL Boskey 2004 In vitro effects of dentin matrix protein-1 on hydroxyapatite formation provide insights into in vivo functions J Biol Chem 279 18115 18120 10.1074/jbc.M314114200 1:CAS:528:DC%2BD2cXjsVKntrc%3D 14769788 (Pubitemid 38623223)
42. B Lorenz-Depiereux M Bastepe A et-Pages M Amyere J Wagenstaller U Muller-Barth K Badenhoop SM Kaiser RS Rittmaster AH Shlossberg JL Olivares C Loris FJ Ramos F Glorieux M Vikkula H Juppner TM Strom 2006 DMP1 mutations in autosomal recessive hypophosphatemia implicate a bone matrix protein in the regulation of phosphate homeostasis Nat Genet 38 1248 1250 10.1038/ng1868 1:CAS:528:DC%2BD28XhtFeisbvN 17033625 (Pubitemid 44646286)
43. S Liu J Zhou W Tang R Menard JQ Feng LD Quarles 2008 Pathogenic role of Fgf23 in Dmp1-null mice Am J Physiol Endocrinol Metab 295 E254 E261 10.1152/ajpendo.90201.2008 1:CAS:528:DC%2BD1cXhtVaktr3P 18559986
44. T Larsson U Nisbeth O Ljunggren H Jüppner KB Jonsson 2003 Circulating concentration of FGF-23 increases as renal function declines in patients with chronic kidney disease, but does not change in response to variation in phosphate intake in healthy volunteers Kidney Int 64 2272 2279 10.1046/j.1523-1755.2003.00328.x 1:CAS:528:DC%2BD3sXpvFOqtLw%3D 14633152 (Pubitemid 37449564)
45. EA Imel M Peacock P Pitukcheewanont HJ Heller LM Ward D Shulman M Kassem P Rackoff M Zimering A Dalkin E Drobny G Colussi JL Shaker EH Hoogendoorn SL Hui MJ Econs 2006 Sensitivity of fibroblast growth factor 23 measurements in tumor-induced osteomalacia J Clin Endocrinol Metab 91 2055 2061 10.1210/jc.2005-2105 1:CAS:528:DC%2BD28XlvVCgsrs%3D 16551733 (Pubitemid 43854981)
46. OM Gutierrez M Mannstadt T Isakova JA Rauh-Hain H Tamez A Shah K Smith H Lee R Thadhani H Jüppner M Wolf 2008 Fibroblast growth factor 23 and mortality among patients undergoing hemodialysis N Engl J Med 359 584 592 10.1056/NEJMoa0706130 1:CAS:528:DC%2BD1cXpt12qtro%3D 18687639
47. Shimada T, Urakawa I, Isakova T, Yamazaki Y, Epstein M, Wesseling-Perry K, Wolf M, Salusky IB, Jüppner H (2009) Circulating fibroblast growth factor 23 in patients with end-stage renal disease treated by peritoneal dialysis is intact and biologically active. J Clin Endocrinol Metab. doi: 10.1210/jc.2009-1603
48. T Shigematsu JJ Kazama T Yamashita S Fukumoto T Hosoya F Gejyo M Fukagawa 2004 Possible involvement of circulating fibroblast growth factor 23 in the development of secondary hyperparathyroidism associated with renal insufficiency Am J Kidney Dis 44 250 256 10.1053/j.ajkd.2004.04.029 1:CAS:528: DC%2BD2cXnt1Srsrk%3D 15264182 (Pubitemid 38962552)
49. D Fliser B Kollerits U Neyer DP Ankerst K Lhotta A Lingenhel E Ritz F Kronenberg E Kuen P Konig G Kraatz JF Mann GA Muller H Kohler P Riegler 2007 Fibroblast growth factor 23 (FGF23) predicts progression of chronic kidney disease: the Mild to Moderate Kidney Disease (MMKD) Study J Am Soc Nephrol 18 2600 2608 10.1681/ASN.2006080936 1:CAS:528:DC%2BD2sXhtV2murvM 17656479 (Pubitemid 47378877)
50. Y Lu L Ye S Yu S Zhang Y Xie MD McKee YC Li J Kong JD Eick SL Dallas JQ Feng 2007 Rescue of odontogenesis in Dmp1-deficient mice by targeted re-expression of DMP1 reveals roles for DMP1 in early odontogenesis and dentin apposition in vivo Dev Biol 303 191 201 10.1016/j.ydbio.2006.11.001 1:CAS:528:DC%2BD2sXhvVGgsb4%3D 17196192 (Pubitemid 46241097)
51. Y Lu S Liu Y Xie S Yu L Quarles LF Bonewald JQ Feng 2007 Use of the transgenic approach to determine the role of DMP1 in phosphate regulation J Musculoskelet Neuronal Interact 7 309 1:STN:280:DC%2BD2sjls1Wisw%3D%3D 18094487
52. B Huang I Maciejewska Y Sun T Peng D Qin Y Lu L Bonewald WT Butler J Feng C Qin 2008 Identification of full-length dentin matrix protein 1 in dentin and bone Calcif Tissue Int 82 401 410 10.1007/s00223-008-9140-7 1:CAS:528: DC%2BD1cXnsVCmsL4%3D 18488132
53. G He S Gajjeraman D Schultz D Cookson C Qin WT Butler J Hao A George 2005 Spatially and temporally controlled biomineralization is facilitated by interaction between self-assembled dentin matrix protein 1 and calcium phosphate nuclei in solution Biochemistry 44 16140 16148 10.1021/bi051045l 1:CAS:528:DC%2BD2MXht1Wisb%2FO 16331974 (Pubitemid 41785812)